These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6407380)

  • 41. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic effects of intravenous administration of olprinone hydrochloride on experimental pulmonary hypertension.
    Kakura H; Miyahara K; Amitani S; Sohara H; Koga M; Sakamoto H; Misumi K; Miura N
    Arzneimittelforschung; 2000 Jun; 50(6):515-9. PubMed ID: 10918942
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Development of tolerance to the hemodynamic effects of nitroglycerin].
    Schlup P; Zatti C; Studer H
    Schweiz Med Wochenschr; 1980 Dec; 110(50):1927-30. PubMed ID: 6782669
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of nitroglycerin and isosorbiddinitrate on myocardial perfusion and hemodynamics in patients with and without coronary disease.
    Simon R; Amende I; Engel HJ; Lichtlen PR
    Scand J Clin Lab Invest Suppl; 1984; 173():47-58. PubMed ID: 6442002
    [No Abstract]   [Full Text] [Related]  

  • 45. [Effect of nifedipine on hemodynamics in precapillary pulmonary hypertension at rest and during exertion].
    Gassner A; Pichler M; Fridrich L; Sykora J; Tizek H; Lenz K
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1790-4. PubMed ID: 6641530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nitroglycerin therapy in the management of pulmonary hypertensive disorders.
    Packer M; Halperin JL; Brooks KM; Rothlauf EB; Lee WH
    Am J Med; 1984 Jun; 76(6A):67-75. PubMed ID: 6430080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hemodynamic effects of i.v. diltiazem in primary pulmonary hypertension. Presentation of 2 clinical cases and review of the literature].
    Richichi G; Zingales LD; Cesari D; Roncella A
    Minerva Cardioangiol; 1986 Oct; 34(10):633-40. PubMed ID: 3808331
    [No Abstract]   [Full Text] [Related]  

  • 48. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
    Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B
    Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute circulatory effects of dopamine in patients with pulmonary hypertension.
    Holloway EL; Polumbo RA; Harrison DC
    Br Heart J; 1975 May; 37(5):482-5. PubMed ID: 1137657
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic-hemodynamic studies of intravenous nitroglycerin in congestive cardiac failure.
    Armstrong PW; Armstrong JA; Marks GS
    Circulation; 1980 Jul; 62(1):160-6. PubMed ID: 6769608
    [No Abstract]   [Full Text] [Related]  

  • 51. Acute effect of nitroglycerin on haemodynamics of angina pectoris.
    Arborelius M; Lecerof H; Malm A; Malmborg RO
    Br Heart J; 1968 May; 30(3):407-11. PubMed ID: 4967901
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
    Bando M; Ishii Y; Kitamura S; Ohno S
    Respiration; 1998; 65(1):63-70. PubMed ID: 9523370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hemodynamic effects of intravenous nitroglycerin in pediatric patients after heart surgery.
    Ilbawi MN; Idriss FS; DeLeon SY; Berry TE; Duffy CE; Paul MH
    Circulation; 1985 Sep; 72(3 Pt 2):II101-7. PubMed ID: 3928187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension.
    Murali S; Uretsky BF; Armitage JM; Tokarczyk TR; Betschart AR; Kormos RL; Stein KL; Reddy PS; Hardesty RL; Griffith BP
    J Heart Lung Transplant; 1992; 11(4 Pt 1):716-23. PubMed ID: 1498137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
    Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
    Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Partial reversibility of chronic pulmonary hypertension caused by pulmonary thromboembolic disease.
    Dantzker DR; Bower JS
    Am Rev Respir Dis; 1981 Aug; 124(2):129-31. PubMed ID: 6789732
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of pulmonary hypertension with transdermal nitroglycerin.
    Daum S; Heinl KW
    Eur J Respir Dis Suppl; 1986; 146():487-93. PubMed ID: 3096761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute hemodynamic effects of intravenous adenosine in patients with associated pulmonary arterial hypertension: Comparison with intravenous epoprostenol.
    Rossi R; Coppi F; Sgura F; Monopoli D; Boriani G
    Pulm Pharmacol Ther; 2018 Apr; 49():147-151. PubMed ID: 28642014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of sublingual nitroglycerin in patients with acute myocardial infarction.
    Delgado CE; Pitt B; Taylor DR; Weisfeldt ML; Kelly DT
    Br Heart J; 1975 Apr; 37(4):392-6. PubMed ID: 804910
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodynamic response to glyceryl trinitrate in a spray at rest and during exercise in a sitting position.
    Chevigné M; Collignon P; Kulbertus H
    Cardiology; 1982; 69(2):84-90. PubMed ID: 6809331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.